Microbot Medical Inc (MBOT)

$3.07 -0.02 (-0.65%)
Market Cap 140.74M
Revenue (ttm) 0.00
Net Income (ttm) -11.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,165,293
Avg Vol 1,748,630
Day's Range N/A - N/A
Shares Out 45.55M
Stochastic %K 79%
Beta 1.15
Analysts Strong Sell
Price Target $9.00

Company Profile

Microbot Medical Inc., a clinical-stage medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space in Israel and the United States. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 781-875-3605
Address:
175 Derby Street, Bld. 27, Hingham, United States
Olena
Olena Aug. 18 at 7:12 PM
$MBOT I think it will be this week.
0 · Reply
Barok
Barok Aug. 18 at 6:47 PM
$RR $SERV $MBOT CNBC really pumping robotics today. Let's go!
0 · Reply
CalculatedSwing
CalculatedSwing Aug. 18 at 6:33 PM
$SDOT it'll be over 1.20 in 3 weeks. $ONDS $AMD $KITT $MBOT $KDLY
0 · Reply
Djmorri
Djmorri Aug. 18 at 5:51 PM
$MBOT. If you held some Fubo, would you sell it and buy more Mbot? Asking for a friend 🤣😎
2 · Reply
OnceBroke_nowAbroker
OnceBroke_nowAbroker Aug. 18 at 5:18 PM
$MBOT who has source to confirm? Cant find on sub???!
1 · Reply
Iudiehard1
Iudiehard1 Aug. 18 at 5:17 PM
$MBOT
0 · Reply
bwilly023
bwilly023 Aug. 18 at 5:15 PM
$MBOT hold for gold baby
0 · Reply
Marcusjoback
Marcusjoback Aug. 18 at 5:09 PM
$MBOT has been working with $SYK for the last 3 years to develop Liberty procedural kits and I’m expecting a huge distribution deal upon FDA approval so we can immediately tap into this Billion dollar market and Stryker's existing massive Sales channel so we will NOT BE BRINGING THIS TO MARKET ALONE and need I remind you that Stryker's annual sales are $23 Billion! ✌️
2 · Reply
cremeegggorilla
cremeegggorilla Aug. 18 at 5:09 PM
$MBOT very excited for the next few weeks
0 · Reply
Daquanladariusblackman2
Daquanladariusblackman2 Aug. 18 at 4:56 PM
$MBOT love the stability over $3
0 · Reply
Latest News on MBOT
Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

Aug 5, 2025, 8:30 AM EDT - 13 days ago

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Jul 22, 2025, 8:30 AM EDT - 27 days ago

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

Jul 8, 2025, 8:30 AM EDT - 5 weeks ago

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

Microbot Medical® Added to the Russell Microcap® Index

Jun 30, 2025, 8:30 AM EDT - 7 weeks ago

Microbot Medical® Added to the Russell Microcap® Index

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

Jun 17, 2025, 8:30 AM EDT - 2 months ago

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

Jun 9, 2025, 8:30 AM EDT - 2 months ago

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

Jun 5, 2025, 8:30 AM EDT - 2 months ago

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

Apr 23, 2025, 8:30 AM EDT - 4 months ago

Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

Apr 9, 2025, 8:30 AM EDT - 4 months ago

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

REMINDER: Microbot Medical Announces Data from the Company's ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

Apr 1, 2025, 8:30 AM EDT - 4 months ago

REMINDER: Microbot Medical Announces Data from the Company's ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

Mar 4, 2025, 8:30 AM EST - 5 months ago

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

Feb 25, 2025, 8:30 AM EST - 6 months ago

Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

Microbot Medical Closes $13 Million Registered Direct Offering

Feb 11, 2025, 6:15 PM EST - 6 months ago

Microbot Medical Closes $13 Million Registered Direct Offering

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Feb 10, 2025, 8:00 AM EST - 6 months ago

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Closes $8.6 Million Registered Direct Offering

Jan 10, 2025, 10:25 AM EST - 7 months ago

Microbot Medical Closes $8.6 Million Registered Direct Offering

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Jan 7, 2025, 4:15 PM EST - 7 months ago

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Dec 30, 2024, 8:30 AM EST - 8 months ago

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Dec 10, 2024, 10:18 AM EST - 8 months ago

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Oct 15, 2024, 8:38 AM EDT - 10 months ago

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Sep 30, 2024, 8:30 AM EDT - 11 months ago

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Sep 17, 2024, 8:30 AM EDT - 11 months ago

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

Aug 22, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

Aug 13, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

Aug 1, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

Jul 9, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

Jul 8, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

Jul 3, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

Jun 20, 2024, 8:25 AM EDT - 1 year ago

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

Jun 17, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jun 4, 2024, 4:20 PM EDT - 1 year ago

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jun 3, 2024, 12:11 PM EDT - 1 year ago

Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial

Jun 3, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial

Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™

Apr 29, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™

Microbot Medical Shares Status Following Recent Geopolitical Events

Apr 15, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Shares Status Following Recent Geopolitical Events

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

Feb 5, 2024, 7:30 AM EST - 1 year ago

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters

Jan 30, 2024, 7:20 AM EST - 1 year ago

Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters

Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study

Jan 18, 2024, 7:20 AM EST - 1 year ago

Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

Dec 29, 2023, 8:00 AM EST - 1 year ago

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met

Dec 28, 2023, 7:30 AM EST - 1 year ago

Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met

Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic

Dec 14, 2023, 8:15 AM EST - 1 year ago

Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic

Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study

Dec 7, 2023, 8:00 AM EST - 1 year ago

Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study

Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities

Nov 21, 2023, 9:12 AM EST - 1 year ago

Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities

Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process

Nov 13, 2023, 8:30 AM EST - 1 year ago

Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process

Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office

Nov 8, 2023, 9:10 AM EST - 1 year ago

Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office

Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical Study

Oct 31, 2023, 8:25 AM EDT - 1 year ago

Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical Study

Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024

Oct 24, 2023, 8:19 AM EDT - 1 year ago

Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024

Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against Company

Oct 19, 2023, 8:20 AM EDT - 1 year ago

Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against Company

Microbot Medical Announces Successful Initial Outcomes from Its Pivotal Pre-Clinical Study with the LIBERTY® Robotic Surgical System

Oct 17, 2023, 9:28 AM EDT - 1 year ago

Microbot Medical Announces Successful Initial Outcomes from Its Pivotal Pre-Clinical Study with the LIBERTY® Robotic Surgical System

Microbot Medical Engages CRO to Support its Upcoming U.S. Pivotal Clinical Trial

Sep 27, 2023, 8:30 AM EDT - 2 years ago

Microbot Medical Engages CRO to Support its Upcoming U.S. Pivotal Clinical Trial

Olena
Olena Aug. 18 at 7:12 PM
$MBOT I think it will be this week.
0 · Reply
Barok
Barok Aug. 18 at 6:47 PM
$RR $SERV $MBOT CNBC really pumping robotics today. Let's go!
0 · Reply
CalculatedSwing
CalculatedSwing Aug. 18 at 6:33 PM
$SDOT it'll be over 1.20 in 3 weeks. $ONDS $AMD $KITT $MBOT $KDLY
0 · Reply
Djmorri
Djmorri Aug. 18 at 5:51 PM
$MBOT. If you held some Fubo, would you sell it and buy more Mbot? Asking for a friend 🤣😎
2 · Reply
OnceBroke_nowAbroker
OnceBroke_nowAbroker Aug. 18 at 5:18 PM
$MBOT who has source to confirm? Cant find on sub???!
1 · Reply
Iudiehard1
Iudiehard1 Aug. 18 at 5:17 PM
$MBOT
0 · Reply
bwilly023
bwilly023 Aug. 18 at 5:15 PM
$MBOT hold for gold baby
0 · Reply
Marcusjoback
Marcusjoback Aug. 18 at 5:09 PM
$MBOT has been working with $SYK for the last 3 years to develop Liberty procedural kits and I’m expecting a huge distribution deal upon FDA approval so we can immediately tap into this Billion dollar market and Stryker's existing massive Sales channel so we will NOT BE BRINGING THIS TO MARKET ALONE and need I remind you that Stryker's annual sales are $23 Billion! ✌️
2 · Reply
cremeegggorilla
cremeegggorilla Aug. 18 at 5:09 PM
$MBOT very excited for the next few weeks
0 · Reply
Daquanladariusblackman2
Daquanladariusblackman2 Aug. 18 at 4:56 PM
$MBOT love the stability over $3
0 · Reply
RandomInvestor777
RandomInvestor777 Aug. 18 at 4:36 PM
$MBOT FDA approval any day, as you can see from their database they approve from monday - friday but only update the database every monday
0 · Reply
Ahsgdg
Ahsgdg Aug. 18 at 4:03 PM
$MBOT bollinger bands tightening on the smaller timeframes, could see a short term pop end of day today, or in the coming days👀
0 · Reply
Sexychart
Sexychart Aug. 18 at 3:58 PM
$TNXP $MBOT $PPCB watching and waiting 🕵‍♂️👀🔍⏱️🛒
0 · Reply
Barok
Barok Aug. 18 at 3:57 PM
$RR $SERV $MBOT More news please
0 · Reply
Foreverbagholding
Foreverbagholding Aug. 18 at 3:29 PM
$MBOT someone literally said FDA approval is priced in lol you’ve gotta be kidding me
4 · Reply
FLNY
FLNY Aug. 18 at 3:00 PM
$MBOT
0 · Reply
Sexychart
Sexychart Aug. 18 at 2:47 PM
$RAYA $PPCB $ORIS $MBOT cookin 👨‍🍳👩‍🍳🔥
1 · Reply
StarTrader1928
StarTrader1928 Aug. 18 at 2:39 PM
$MBOT new April option series opened on Friday. The April 5’s with 8 months til expiration good value at 0.35-.40 imo. That’s a shit ton of time for the risk.
0 · Reply
Charris20
Charris20 Aug. 18 at 2:21 PM
$MBOT Realistically, what should the price of MBOT be after FDA approval?
5 · Reply
Barok
Barok Aug. 18 at 2:05 PM
$RR $SERV $MBOT keep the robotics news flow coming
0 · Reply
Theryanzamo
Theryanzamo Aug. 18 at 1:45 PM
$SERV along with my other millionaire-maker robotic stock $MBOT just keeeeeep making me moneyyyyy 🚀🚀🚀🍾
0 · Reply
Snakewatching
Snakewatching Aug. 18 at 12:17 PM
$MBOT just added more shares pre-market, I would rather buy more now, then when it's 5, 6 or 7 dollars...
0 · Reply